What is Apogee Therapeutics, Inc.'s income tax?

Apogee Therapeutics, Inc. (APGE) reported income tax of $79K in Q1 2026.

How has Apogee Therapeutics, Inc.'s income tax changed year-over-year?

Apogee Therapeutics, Inc.'s income tax decreased by 4.8% year-over-year, from $83K to $79K.

What does income tax mean?

Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.

Apogee Therapeutics, Inc. APGE Income Tax

Income Tax at other companies

Eli LillyLLY

$1.45B+109%

Regeneron PharmaceuticalsREGN

$104M+8.0%

AbbVieABBV

$342M-8.1%

Arrowhead ResearchARWR

$7K-99.6%

Immunovant, Inc.IMVT

——

Protagonist TherapeuticsPTGX

——

Segments

By segment

See full

Reportable Segment Aggregation Before Other Operating$79K-4.8%

Other financials

Income statement

See full

Operating income-$82.8M-31.2%

Net income-$74.1M-33.9%

EPS (diluted)-$1.06-11.6%

Balance sheet

See full

Cash & equivalents$451.8M+323%

Total debt$8.0M-31.9%

Total assets$1.3B+81.1%

Cash flow

See full

Operating cash flow-$55.6M-14.6%

CapEx$62.0K—

Free cash flow-$62.8M+7.3%

Valuation

See full

Market cap$6.81B+189%

Enterprise value$6.37B+181%

Returns & leverage

See full

Current ratio32.6×+16.8×

Where this comes from

Reported directly by Apogee Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apogee Therapeutics, Inc.'s income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Apogee Therapeutics, Inc.'s income tax?: Apogee Therapeutics, Inc. (APGE) reported income tax of $79K in Q1 2026.
How has Apogee Therapeutics, Inc.'s income tax changed year-over-year?: Apogee Therapeutics, Inc.'s income tax decreased by 4.8% year-over-year, from $83K to $79K.
What does income tax mean?: Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.